Effluent from drug manufactures contains extremely high levels of pharmaceuticals.

By D. Larsson, C. de Pedro, N. Paxéus. Journal of Hazardous Materials, 2007

1,506 citations recorded by the source corpus.

Subfields: Environmental Chemistry, Health, Toxicology and Mutagenesis, Pollution

View Paper: https://www.semanticscholar.org/paper/6f1a4faa4508c4595e706a137e39bbef5bf5a19e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Environmental Chemistry

1. K. Kümmerer
2. M. Cleuvers

In Health, Toxicology and Mutagenesis

1. K. Kümmerer
2. L. Serwecińska
3. T. Heberer
4. Dan J. Lapworth
5. M. Stuart
6. A. Coors
7. M. Cleuvers
8. Lianfeng Du

In Pollution

1. L. Serwecińska
2. K. Kümmerer
3. D. Larsson
4. T. Heberer
5. D. Hughes
6. D. Andersson
7. Dan J. Lapworth
8. M. Stuart

Citations in the corpus

• Human Health Risk Assessment (HHRA) for Environmental Development and Transfer of Antibiotic Resistance (2013, background): “2011), intensive ani­ mal husbandry, and waste from the manu­ facture of pharmaceuticals (Larsson et al. 2007).”
• Contamination of surface, ground, and drinking water from pharmaceutical production (2009, background): “It is also evident that the levels of fluoroquinolones measured will have ecotoxicological effects, particularly on microbial ecosystems [9,27,28].”
• Degradation of selected pharmaceutical and personal care products (PPCPs) by white-rot fungi (2011, background): “Previous studies detected PPCP concentrations in the environment in the range of nanograms per liter (ng/l) to micrograms per liter (lg/l) (Clara et al. 2005; Ikehata et al. 2006; Kim et al. 2009; Larsson et al. 2007; Reif et al. 2008; Suárez et al. 2008; Zucatto et al. 2006).”
• Review of risk from potential emerging contaminants in UK groundwater. (2012, background): “Manufacturing sites may also contribute (Larsson, 2008; Larsson et al., 2007).”
• The presence of pharmaceuticals in the environment due to human use--present knowledge and future challenges. (2009, background): “Therefore, the concentrations to be used during testing may be different, i.e. lower for surface water than for sewage and higher with respect to local situations such as those reported at production sites (Larsson et al., 2007; Li et al., 2008a,b; Thomas et al., 2007).”
• Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer (2016, background): “…that a treatment plant in India, receiving water from drug manufacturing sites, exposes its direct environment to very high levels of antibiotics, discharging∼45 kg of ciprofloxacin per day (Larsson et al., 2007), contaminating surface, ground, and drinking water in the area (Fick et al., 2009).”